Insider Trading activities of Intellia Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Intellia Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Intellia Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Intellia Therapeutics, Inc. since 2005. The reporting company's ticker symbol is NTLA. The reporting company's CIK number is 1652130.
The total value of stock buying since 2005 is $22,999,986.
The total value of stock sales since 2005 is $5,458,598.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Intellia Therapeutics, Inc. (NTLA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 0 $0 1,048,846 $0 0 $0
2017-07 0 $0 300,000 $4,870,918 0 $0
2017-03 0 $0 42,264 $587,680 0 $0
2016-05 1,277,777 $22,999,986 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Intellia Therapeutics, Inc. insiders (NTLA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-13 Caribou Biosciences, Inc. Sale 1,048,846 .00 0
2017-07-11 Atlas Venture Associates Ix, Llc (10% Owner) Sale 80,000 16.07 1,285,600
2017-07-11 Formela Jean Francois (Director) Sale 80,000 16.07 1,285,600
2017-07-10 Atlas Venture Associates Ix, Llc (10% Owner) Sale 40,000 16.17 646,880
2017-07-10 Formela Jean Francois (Director) Sale 40,000 16.17 646,880
2017-07-07 Atlas Venture Associates Ix, Llc (10% Owner) Sale 30,000 16.77 502,979
2017-07-07 Formela Jean Francois (Director) Sale 30,000 16.77 502,979
2017-03-10 Atlas Venture Associates Ix, Llc (10% Owner) Sale 5,504 14.06 77,408
2017-03-10 Formela Jean Francois (Director) Sale 5,504 14.06 77,408
2017-03-09 Atlas Venture Associates Ix, Llc (10% Owner) Sale 15,628 13.85 216,432
2017-03-09 Formela Jean Francois (Director) Sale 15,628 13.85 216,432
2016-05-11 Tls Beta Pte. Ltd. (10% Owner) Buy 300,000 18.00 5,400,000
2016-05-11 Baker Bros. Advisors (gp) Llc (Other) Buy 200,000 18.00 3,600,000
2016-05-11 Gordon Carl L (Director) Buy 250,000 18.00 4,500,000
2016-05-11 Novartis Ag (10% Owner) Buy 277,777 18.00 4,999,986
2016-05-11 Isaly Samuel D (Director) Buy 250,000 18.00 4,500,000

Insider trading activities including stock purchases, stock sales, and option exercises of NTLA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Intellia Therapeutics, Inc. (symbol NTLA, CIK number 1652130) see the Securities and Exchange Commission (SEC) website.